Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery

Type 2 diabetes mellitus (T2DM) is one of the largest public health problems worldwide. Insulin resistance-related metabolic dysfunction and chronic hyperglycemia result in devastating complications and poor prognosis. Even though there are many conventional drugs such as metformin (MET), Thiazolidi...

Full description

Bibliographic Details
Main Authors: Jinjoo Lee, Seungjin Noh, Suhyun Lim, Bonglee Kim
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/1/81
_version_ 1797414227369000960
author Jinjoo Lee
Seungjin Noh
Suhyun Lim
Bonglee Kim
author_facet Jinjoo Lee
Seungjin Noh
Suhyun Lim
Bonglee Kim
author_sort Jinjoo Lee
collection DOAJ
description Type 2 diabetes mellitus (T2DM) is one of the largest public health problems worldwide. Insulin resistance-related metabolic dysfunction and chronic hyperglycemia result in devastating complications and poor prognosis. Even though there are many conventional drugs such as metformin (MET), Thiazolidinediones (TZDs), sulfonylureas (SUF), dipeptidyl peptidase 4 (DPP-4) inhibitors, glucagon like peptide 1 (GLP-1) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors, side effects still exist. As numerous plant extracts with antidiabetic effects have been widely reported, they have the potential to be a great therapeutic agent for type 2 diabetes with less side effects. In this study, sixty-five recent studies regarding plant extracts that alleviate type 2 diabetes were reviewed. Plant extracts regulated blood glucose through the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway. The anti-inflammatory and antioxidant properties of plant extracts suppressed c-Jun amino terminal kinase (JNK) and nuclear factor kappa B (NF-κB) pathways, which induce insulin resistance. Lipogenesis and fatty acid oxidation, which are also associated with insulin resistance, are regulated by AMP-activated protein kinase (AMPK) activation. This review focuses on discovering plant extracts that alleviate type 2 diabetes and exploring its therapeutic mechanisms.
first_indexed 2024-03-09T05:29:05Z
format Article
id doaj.art-2d36e575103a430693f70e36c0fbc677
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-09T05:29:05Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-2d36e575103a430693f70e36c0fbc6772023-12-03T12:33:41ZengMDPI AGAntioxidants2076-39212021-01-011018110.3390/antiox10010081Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug DiscoveryJinjoo Lee0Seungjin Noh1Suhyun Lim2Bonglee Kim3College of Korean Medicine, Kyung Hee University, Seoul 02447, KoreaCollege of Korean Medicine, Kyung Hee University, Seoul 02447, KoreaCollege of Korean Medicine, Kyung Hee University, Seoul 02447, KoreaCollege of Korean Medicine, Kyung Hee University, Seoul 02447, KoreaType 2 diabetes mellitus (T2DM) is one of the largest public health problems worldwide. Insulin resistance-related metabolic dysfunction and chronic hyperglycemia result in devastating complications and poor prognosis. Even though there are many conventional drugs such as metformin (MET), Thiazolidinediones (TZDs), sulfonylureas (SUF), dipeptidyl peptidase 4 (DPP-4) inhibitors, glucagon like peptide 1 (GLP-1) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors, side effects still exist. As numerous plant extracts with antidiabetic effects have been widely reported, they have the potential to be a great therapeutic agent for type 2 diabetes with less side effects. In this study, sixty-five recent studies regarding plant extracts that alleviate type 2 diabetes were reviewed. Plant extracts regulated blood glucose through the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway. The anti-inflammatory and antioxidant properties of plant extracts suppressed c-Jun amino terminal kinase (JNK) and nuclear factor kappa B (NF-κB) pathways, which induce insulin resistance. Lipogenesis and fatty acid oxidation, which are also associated with insulin resistance, are regulated by AMP-activated protein kinase (AMPK) activation. This review focuses on discovering plant extracts that alleviate type 2 diabetes and exploring its therapeutic mechanisms.https://www.mdpi.com/2076-3921/10/1/81diabetes mellitusplant extractsantioxidantglucose transportinflammationlipid metabolism
spellingShingle Jinjoo Lee
Seungjin Noh
Suhyun Lim
Bonglee Kim
Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery
Antioxidants
diabetes mellitus
plant extracts
antioxidant
glucose transport
inflammation
lipid metabolism
title Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery
title_full Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery
title_fullStr Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery
title_full_unstemmed Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery
title_short Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery
title_sort plant extracts for type 2 diabetes from traditional medicine to modern drug discovery
topic diabetes mellitus
plant extracts
antioxidant
glucose transport
inflammation
lipid metabolism
url https://www.mdpi.com/2076-3921/10/1/81
work_keys_str_mv AT jinjoolee plantextractsfortype2diabetesfromtraditionalmedicinetomoderndrugdiscovery
AT seungjinnoh plantextractsfortype2diabetesfromtraditionalmedicinetomoderndrugdiscovery
AT suhyunlim plantextractsfortype2diabetesfromtraditionalmedicinetomoderndrugdiscovery
AT bongleekim plantextractsfortype2diabetesfromtraditionalmedicinetomoderndrugdiscovery